Indian Pharmacopoeia Commission
Ranjana Nishad is a seasoned clinical research professional currently serving as a Clinical Research Coordinator at AIIMS-Gorakhpur since May 2022. Concurrently, Ranjana has been working as a Pharmacovigilance Associate at the ADR Monitoring Centre of AIIMS-Gorakhpur under the Indian Pharmacopoeia Commission since December 2020, focusing on monitoring adverse drug reactions (ADRs) in various hospital wards. Prior experience includes a role as a Junior Pharmacovigilance Associate at the Government Institute of Medical Sciences and a Junior Executive position at Steril Gene Life Sciences Private Limited. Ranjana holds a Master of Pharmacy in Pharmacy Practice from the National Institute of Pharmaceutical Education & Research, Guwahati, and a Bachelor of Pharmacy from Kailash Institute of Pharmacy and Management, Gida, Gorakhpur.
This person is not in any teams
This person is not in any offices
Indian Pharmacopoeia Commission
Indian Pharmacopoeia Commission (IPC) is an autonomous Institution of the Ministry of Health and Family Welfare, Government of India. IPC was created on January 01, 2009, and entrusted with the mandate to set standards for drugs in the country. IPC’s basic function is to regularly update the standards of drugs for their publication in the Indian Pharmacopoeia (IP). IP Reference Standards (IPRS) and Impurities are also developed by the IPC for the quality control analysis of drugs. Additionally, the National Formulary of India (NFI) is published to promote rational use of generic medicines. Since 2012, IPC has been working as the National Coordination Centre for Pharmacovigilance Programme of India (PvPI).